Symbols / IINN $0.57 -5.39%
IINN Chart
About
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 24.67M |
| Enterprise Value | 15.78M | Income | -11.21M | Sales | 289.00K |
| Book/sh | 0.04 | Cash/sh | 0.07 | Dividend Yield | — |
| Payout | 0.00% | Employees | 38 | IPO | — |
| P/E | — | Forward P/E | -0.81 | PEG | — |
| P/S | 85.38 | P/B | 12.67 | P/C | — |
| EV/EBITDA | -1.26 | EV/Sales | 54.61 | Quick Ratio | 0.75 |
| Current Ratio | 1.15 | Debt/Eq | 50.08 | LT Debt/Eq | — |
| EPS (ttm) | -0.48 | EPS next Y | -0.70 | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | -114.39% |
| ROE | -3.39% | ROIC | — | Gross Margin | 0.69% |
| Oper. Margin | -25.03% | Profit Margin | 0.00% | Shs Outstand | 43.27M |
| Shs Float | 27.94M | Short Float | 1.05% | Short Ratio | 0.34 |
| Short Interest | — | 52W High | 1.65 | 52W Low | 0.40 |
| Beta | 2.29 | Avg Volume | 605.99K | Volume | 115.41K |
| Target Price | $5.00 | Recom | None | Prev Close | $0.60 |
| Price | $0.57 | Change | -5.39% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$5.00
Mean price target
2. Current target
$0.57
Latest analyst target
3. DCF / Fair value
$-2.67
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.57
Low
$5.00
High
$5.00
Mean
$5.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-06-02 | init | Litchfield Hills | — → Buy | $2 |
- Why a $49.5M life-support tech deal is now aligned with 2026 milestones - Stock Titan ue, 23 Dec 2025 08
- Inspira Technologies Oxy B.H.N. (IINN) Price Target Increased by 66.67% to 5.10 - Nasdaq Wed, 29 Oct 2025 07
- When Will Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) Become Profitable? - Yahoo Finance Wed, 03 Sep 2025 07
- Inspira Technologies Oxy B.H.N. Ltd.'s (NASDAQ:IINN) Path To Profitability - simplywall.st Wed, 24 Sep 2025 07
- Should I buy Inspira Technologies OXY (IINN) - Zacks Investment Research Mon, 22 Sep 2025 07
- Why Did IINN Stock Surge 28% In Pre-Market Today? - Stocktwits Mon, 09 Feb 2026 08
- Inspira Technologies Announces Proposed Acquisition of Liquid Biopsy Diagnostics Business and $15 Million Strategic Equity Investment - Quiver Quantitative Mon, 05 Jan 2026 08
- Inspira Technologies stock rises after outlining liquid biopsy expansion plan - Investing.com hu, 08 Jan 2026 08
- Inspira Technologies (NASDAQ: IINN) upgrades lab to boost blood diagnostics platform - Stock Titan Wed, 03 Dec 2025 08
- Inspira Technologies Amends Bio-View Debenture and Faces Nasdaq Market Value Deficiency Notice - TipRanks Wed, 25 Feb 2026 08
- All You Need to Know About Inspira Technologies OXY (IINN) Rating Upgrade to Buy - Nasdaq Mon, 22 Sep 2025 07
- Inspira Technologies Receives US Patent Clearance For Core Technology Of Its ART500 Device: Retail Loads Up On The Stock - Stocktwits Fri, 22 Aug 2025 18
- Inspira Technologies outlines liquid biopsy acquisition strategy - Investing.com hu, 08 Jan 2026 08
- Two Inspira government deals enter final budget review stage - Stock Titan Wed, 21 Jan 2026 08
- Inspira Technologies Moves Into Liquid Biopsy With Planned Acquisition and $15 Million Strategic Investment - TipRanks Mon, 05 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -11.17M | -12.25M | -14.26M | -16.94M |
| TotalUnusualItems | 77.00K | 233.00K | -530.00K | -113.00K |
| TotalUnusualItemsExcludingGoodwill | 77.00K | 233.00K | -530.00K | -113.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -11.05M | -11.29M | -14.98M | -17.19M |
| ReconciledDepreciation | 171.00K | 111.00K | 54.00K | 25.00K |
| EBITDA | -11.10M | -12.02M | -14.79M | -17.05M |
| EBIT | -11.27M | -12.13M | -14.89M | -17.13M |
| NetInterestIncome | 137.00K | 614.00K | 447.00K | -4.12M |
| InterestExpense | 0.00 | 37.00K | 59.00K | |
| InterestIncome | 172.00K | 318.00K | 192.00K | 1.00K |
| NormalizedIncome | -11.13M | -11.52M | -14.45M | -17.08M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -11.05M | -11.29M | -14.98M | -17.19M |
| TotalExpenses | 11.27M | 12.13M | 14.89M | 12.96M |
| TotalOperatingIncomeAsReported | -11.27M | -12.13M | -14.89M | -12.96M |
| DilutedAverageShares | 12.10M | 11.34M | 5.31M | |
| BasicAverageShares | 12.10M | 11.34M | 5.31M | |
| DilutedEPS | -0.93 | -0.91 | -3.24 | |
| BasicEPS | -0.93 | -0.91 | -3.24 | |
| DilutedNIAvailtoComStockholders | -11.05M | -11.29M | -14.98M | -17.19M |
| NetIncomeCommonStockholders | -11.05M | -11.29M | -14.98M | -17.19M |
| NetIncome | -11.05M | -11.29M | -14.98M | -17.19M |
| NetIncomeIncludingNoncontrollingInterests | -11.05M | -11.29M | -14.98M | -17.19M |
| NetIncomeContinuousOperations | -11.05M | -11.29M | -14.98M | -17.19M |
| TaxProvision | 0.00 | 0.00 | 0.00 | 0.00 |
| PretaxIncome | -11.05M | -11.29M | -14.98M | -17.19M |
| OtherIncomeExpense | 77.00K | 233.00K | -530.00K | -113.00K |
| GainOnSaleOfSecurity | 77.00K | 233.00K | -530.00K | -113.00K |
| NetNonOperatingInterestIncomeExpense | 137.00K | 614.00K | 447.00K | -4.12M |
| TotalOtherFinanceCost | 35.00K | -296.00K | -255.00K | 4.06M |
| InterestExpenseNonOperating | 0.00 | 37.00K | 59.00K | |
| InterestIncomeNonOperating | 172.00K | 318.00K | 192.00K | 1.00K |
| OperatingIncome | -11.27M | -12.13M | -14.89M | -12.96M |
| OperatingExpense | 11.27M | 12.13M | 14.89M | 12.96M |
| OtherOperatingExpenses | 140.00K | 133.00K | 109.00K | 68.00K |
| DepreciationAmortizationDepletionIncomeStatement | 117.00K | 115.00K | 104.00K | 84.00K |
| DepreciationAndAmortizationInIncomeStatement | 117.00K | 115.00K | 104.00K | 84.00K |
| DepreciationIncomeStatement | 117.00K | 115.00K | 104.00K | 84.00K |
| ResearchAndDevelopment | 6.32M | 7.32M | 8.18M | 4.07M |
| SellingGeneralAndAdministration | 4.69M | 4.57M | 6.50M | 8.74M |
| SellingAndMarketingExpense | 51.00K | 61.00K | 16.00K | 25.00K |
| GeneralAndAdministrativeExpense | 4.64M | 4.50M | 6.48M | 8.72M |
| OtherGandA | 2.16M | 2.19M | 2.20M | 2.57M |
| InsuranceAndClaims | 196.00K | 300.00K | 557.00K | 363.00K |
| SalariesAndWages | 2.28M | 2.02M | 3.72M | 5.79M |
| TotalRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 24.25M | 15.65M | 11.34M | 10.09M |
| ShareIssued | 24.25M | 15.65M | 11.34M | 10.09M |
| TotalDebt | 655.00K | 878.00K | 1.14M | 1.48M |
| TangibleBookValue | 4.32M | 5.74M | 13.63M | 20.35M |
| InvestedCapital | 4.32M | 5.74M | 13.63M | 20.66M |
| WorkingCapital | 3.44M | 4.81M | 12.83M | 20.19M |
| NetTangibleAssets | 4.32M | 5.74M | 13.63M | 20.35M |
| CapitalLeaseObligations | 655.00K | 878.00K | 1.14M | 1.18M |
| CommonStockEquity | 4.32M | 5.74M | 13.63M | 20.35M |
| TotalCapitalization | 4.32M | 5.74M | 13.63M | 20.66M |
| TotalEquityGrossMinorityInterest | 4.32M | 5.74M | 13.63M | 20.35M |
| StockholdersEquity | 4.32M | 5.74M | 13.63M | 20.35M |
| GainsLossesNotAffectingRetainedEarnings | -1.93M | 210.00K | ||
| ForeignCurrencyTranslationAdjustments | -1.93M | 210.00K | ||
| RetainedEarnings | -66.57M | -55.52M | -44.23M | -28.79M |
| CapitalStock | 70.90M | 61.26M | 57.87M | 48.94M |
| CommonStock | 70.90M | 61.26M | 57.87M | 48.94M |
| TotalLiabilitiesNetMinorityInterest | 3.75M | 3.57M | 2.54M | 5.52M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 378.00K | 588.00K | 873.00K | 1.20M |
| LongTermDebtAndCapitalLeaseObligation | 378.00K | 588.00K | 873.00K | 1.20M |
| LongTermCapitalLeaseObligation | 378.00K | 588.00K | 873.00K | 900.00K |
| LongTermDebt | 398.00K | 302.00K | ||
| CurrentLiabilities | 3.37M | 2.98M | 1.66M | 4.31M |
| OtherCurrentLiabilities | 1.57M | 1.47M | 26.00K | 3.21M |
| CurrentDebtAndCapitalLeaseObligation | 277.00K | 290.00K | 268.00K | 281.00K |
| CurrentCapitalLeaseObligation | 277.00K | 290.00K | 268.00K | 281.00K |
| PayablesAndAccruedExpenses | 1.52M | 1.22M | 1.37M | 818.00K |
| CurrentAccruedExpenses | 922.00K | 655.00K | 866.00K | 421.00K |
| Payables | 596.00K | 569.00K | 502.00K | 397.00K |
| OtherPayable | 21.00K | 17.00K | 18.00K | 29.00K |
| DuetoRelatedPartiesCurrent | 421.00K | 354.00K | 332.00K | 275.00K |
| AccountsPayable | 154.00K | 198.00K | 152.00K | 93.00K |
| TotalAssets | 8.07M | 9.31M | 16.17M | 25.87M |
| TotalNonCurrentAssets | 1.26M | 1.52M | 1.67M | 1.36M |
| NetPPE | 1.26M | 1.52M | 1.67M | 1.36M |
| AccumulatedDepreciation | -370.00K | -199.00K | -88.00K | -34.00K |
| GrossPPE | 1.63M | 1.72M | 1.76M | 1.40M |
| Leases | 36.00K | 36.00K | 33.00K | 7.00K |
| OtherProperties | 1.30M | 1.39M | 1.49M | 1.22M |
| MachineryFurnitureEquipment | 298.00K | 288.00K | 237.00K | 165.00K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 6.81M | 7.79M | 14.49M | 24.51M |
| OtherCurrentAssets | 257.00K | 167.00K | 279.00K | 213.00K |
| RestrictedCash | 90.00K | 89.00K | 56.00K | 120.00K |
| PrepaidAssets | 240.00K | 176.00K | 7.37M | 426.00K |
| Inventory | 444.00K | 0.00 | ||
| FinishedGoods | 293.00K | 0.00 | ||
| WorkInProcess | 55.00K | 0.00 | ||
| RawMaterials | 96.00K | 0.00 | ||
| CashCashEquivalentsAndShortTermInvestments | 5.78M | 7.36M | 6.78M | 23.75M |
| OtherShortTermInvestments | 668.00K | 2.32M | ||
| CashAndCashEquivalents | 5.11M | 5.04M | 6.78M | 23.75M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -9.54M | -9.90M | -9.47M | -6.87M |
| RepaymentOfDebt | -399.00K | -199.00K | ||
| IssuanceOfDebt | 0.00 | 0.00 | 7.20M | |
| IssuanceOfCapitalStock | 7.90M | 3.45M | 0.00 | 23.00M |
| CapitalExpenditure | -164.00K | -206.00K | -263.00K | -182.00K |
| InterestPaidSupplementalData | 72.00K | 93.00K | 106.00K | 29.00K |
| EndCashPosition | 5.20M | 5.13M | 6.84M | 23.87M |
| BeginningCashPosition | 5.13M | 6.84M | 23.87M | 541.00K |
| EffectOfExchangeRateChanges | 55.00K | -65.00K | -438.00K | 954.00K |
| ChangesInCash | 16.00K | -1.64M | -16.59M | 23.33M |
| FinancingCashFlow | 7.90M | 3.45M | 0.00 | 30.20M |
| CashFlowFromContinuingFinancingActivities | 7.90M | 3.45M | 0.00 | 30.20M |
| NetOtherFinancingCharges | -454.00K | |||
| ProceedsFromStockOptionExercised | 4.00K | 3.00K | 0.00 | 0.00 |
| NetCommonStockIssuance | 7.90M | 3.45M | 0.00 | 23.00M |
| CommonStockIssuance | 7.90M | 3.45M | 0.00 | 23.00M |
| NetIssuancePaymentsOfDebt | 0.00 | -399.00K | 7.20M | |
| NetShortTermDebtIssuance | 0.00 | 7.21M | ||
| ShortTermDebtIssuance | 0.00 | 7.21M | ||
| NetLongTermDebtIssuance | 0.00 | -399.00K | 7.20M | |
| LongTermDebtPayments | -399.00K | -199.00K | ||
| LongTermDebtIssuance | 0.00 | 0.00 | 7.20M | |
| InvestingCashFlow | 1.49M | 4.59M | -7.38M | -182.00K |
| CashFlowFromContinuingInvestingActivities | 1.49M | 4.59M | -7.38M | -182.00K |
| NetOtherInvestingChanges | 1.65M | 4.80M | -7.12M | -70.00K |
| NetInvestmentPurchaseAndSale | 4.80M | -7.12M | 0.00 | |
| SaleOfInvestment | 4.80M | 0.00 | 0.00 | |
| PurchaseOfInvestment | 0.00 | -7.12M | 0.00 | |
| NetPPEPurchaseAndSale | -164.00K | -206.00K | -263.00K | -182.00K |
| PurchaseOfPPE | -164.00K | -206.00K | -263.00K | -182.00K |
| OperatingCashFlow | -9.37M | -9.69M | -9.21M | -6.68M |
| CashFlowFromContinuingOperatingActivities | -9.37M | -9.69M | -9.21M | -6.68M |
| ChangeInWorkingCapital | -423.00K | 41.00K | 555.00K | -203.00K |
| ChangeInOtherCurrentAssets | -53.00K | 185.00K | 0.00 | -466.00K |
| ChangeInPayablesAndAccruedExpense | 74.00K | -144.00K | 555.00K | 263.00K |
| ChangeInPayable | 74.00K | -144.00K | 555.00K | 263.00K |
| ChangeInAccountPayable | -44.00K | 46.00K | 59.00K | 91.00K |
| ChangeInPrepaidAssets | -7.00K | -51.00K | -12.00K | |
| ChangeInInventory | -444.00K | 0.00 | 0.00 | |
| OtherNonCashItems | 42.00K | 198.00K | -51.00K | 3.50M |
| StockBasedCompensation | 1.89M | 1.49M | 4.88M | 6.70M |
| UnrealizedGainLossOnInvestmentSecurities | 47.00K | -306.00K | -108.00K | 480.00K |
| DepreciationAmortizationDepletion | 171.00K | 111.00K | 54.00K | 25.00K |
| DepreciationAndAmortization | 171.00K | 111.00K | 54.00K | 25.00K |
| Depreciation | 171.00K | 111.00K | 54.00K | 25.00K |
| OperatingGainsLosses | -50.00K | 65.00K | 438.00K | |
| NetForeignCurrencyExchangeGainLoss | -55.00K | 65.00K | 438.00K | |
| NetIncomeFromContinuingOperations | -11.05M | -11.29M | -14.98M | -17.19M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for IINN
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|